Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-05-14 @ 9:02 PM
Study NCT ID:
NCT06024356
Status:
UNKNOWN
Last Update Posted:
2023-09-06
First Post:
2023-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BFH-TTNCRT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None